Table 2.
Characteristic of study population. Comparison of patient measurements at baseline (V0, n = 27) and after 4 months (V2, n = 24). Values are expressed in median (IQR). Wilcoxon test P‐value reported (*P < .05). IPSS‐QoL corresponds to IPSS question number 8. IIEF‐15 domains
| V0 (n = 27) | V2 (n = 24) | P | |
|---|---|---|---|
| Ultrasound | |||
| PV (mL) | 44.5 (38.0;61.6) | 41.7 (32.7;62.8) | 0.045* |
| Adenome volume (mL) | 16.7 (12.0;27.3) | 13.3 (10.6;24.5) | 0.224 |
| LUTS questionnaire | |||
| IPSS | 11.0 (5.7;3.2) | 9.0 (6.0;14.0) | 0.015* |
| IPSS‐QoL | 3.0 (1.0;3.25) | 1.0 (1.0;2.75) | 0.018* |
| Sexual function questionnaire (IIEF‐15) | |||
| EF | 27.0 (15.0;28.0) | 26.0 (17.7;29.0) | 0.694 |
| IS | 9.0 (7.0;12.0) | 10.0 (9.0;12.0) | 0.561 |
| SD | 7.0 (6.0;9.0) | 8.0 (7.0;8.0) | 0.235 |
| OF | 10.0 (6.0;10.0) | 10.0 (7.2;10.0) | 0.362 |
| OS | 8.0 (4.0;8.0) | 8.0 (6.0;10.0) | 0.179 |
| Hormones | |||
| FSH (mUI/mL) | 7.1 (4.2;12.2) | 6.9 (4.72;11.75) | 0.148 |
| LH (mUI/mL) | 3.4 (2.3;5.9) | 4.2 (2.9;6.1) | 0.498 |
| Testosterone (nmol/L) | 16.0 (13.0;20.3) | 15.2 (13.3;18.7) | 0.205 |
| Estradiol (pg/mL) | 25.0 (20.0;35.0) | 20.0 (16.7;22.5) | 0.172 |
| Lipid and glucose metabolism | |||
| Glycemia (mg/dL) | 97.0 (90.0;108.0) | 95.4 (90;106) | 0.126 |
| HbA1c (%) | 5.5 (5.2;6.1) | 5.5 (5.3;5.9) | 0.189 |
| Total cholesterol (mg/dL) | 183.0 (149.0;196.0) | 180.4 (159.7;209.6) | 0.137 |
| HDL (mg/dL) | 48.0 (42.0;64.0) | 50.3 (43.8;59.0) | 0.568 |
| LDL (mg/dL) | 98.0 (78.0;112.0) | 100.5 (85.4;129.9) | 0.137 |
| Triglycerides (mg/dL) | 110.0 (81.0;135.0) | 92.08 (71.7;156.0) | 0.909 |
| Kidney function | |||
| Creatinine (mg/dL) | 1.0 (0.8;1.2) | 1.0 (0.9;1.2) | 0.123 |
| Urea (mg/dL) | 36.0 (32;41.4) | 36.6 (30.3;42.6) | 0.068 |
| Inflammation markers | |||
| WBCs (×109/L) | 6.7 (5.2;8.2) | 7.0 (5.4;7.9) | 0.784 |
| Neutrophils (×109/L) | 3.7 (2.9;4.7) | 3.8 (3;4.9) | 0.403 |
| Lymphocytes (×109/L) | 1.9 (1.4;2.2) | 1.8 (1.1;2.3) | 0.553 |
| ESR (mm/h) | 9.0 (3.5;15) | 5.0 (3;9.7) | 0.132 |
| CRP (μg/L) | 1600 (600;2500) | 1300 (600;1875) | 0.721 |
| Fibrinogen (g/L) | 3.1 (2.6;3.3) | 3.0 (2.5;3.5) | 0.247 |
| PSA (ng/mL) | 1.9 (0.7;3.6) | 2.3 (0.9;4.7) | 0.366 |
Abbreviations: EF, erectile function; IS, intercourse satisfaction; OF, orgasmic function; OS, overall satisfaction; SD, sexual desire.